Skip to main content

Table 1 Baseline demographics by diagnostic category.

From: Identification of factors associated with good response to growth hormone therapy in children with short stature: results from the ANSWER Program®

  GHD MPHD Turner SGA ISS
  n Mean (SD) n Mean (SD) n Mean (SD) n Mean (SD) n Mean (SD)
Gender           
   Male 543 - 53 - 0 - 33 - 91 -
   Female 155 - 18 - 60 - 17 - 32 -
Age 698 10.9 (3.46) 71 6.4 (5.23) 60 8.5 (4.17) 50 7.1 (3.41) 123 11.2 (2.88)
HSDS 698 -2.2 (0.86) 71 -2.0 (1.36) 60 -2.5 (0.77) 50 -2.8 (0.97) 123 -2.3 (0.68)
IGF-I SDS 605 -2.5 (1.26) 31 -3.2 (1.54) 34 -2.0 (1.43) 32 -2.1 (1.53) 114 -2.2 (1.11)
BMI SDS 681 -0.1 (1.38) 49 0.5 (1.84) 55 0.5 (0.97) 49 -0.8 (1.35) 123 -0.8 (3.38)
Bone Age, yrs 616 9.4 (3.31) 39 8.0 (4.58) 43 7.8 (3.45) 44 6.1 (3.36) 115 9.7 (2.93)
Peak GH, ng/mL 606 5.5 (2.69) 40 3.6 (3.03) 5 12.5 (8.25) 17 13.8 (10.95) 97 15.2 (8.10)
GH dose, μg/kg/day 697 45.9 (10.1) 71 40.6 (11.2) 60 51.9 (9.0) 50 49.9 (13.5) 123 46.1 (8.6)
  1. BMI, body mass index; GH, growth hormone; GHD, growth hormone deficiency; HSDS, height standard deviation score; IGF-I, insulin-like growth factor I; ISS, idiopathic short stature; MPHD, multiple pituitary hormone deficiency; SD, standard deviation; SDS, standard deviation score; SGA, small for gestational age